FI71145C - Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin - Google Patents
Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin Download PDFInfo
- Publication number
- FI71145C FI71145C FI822471A FI822471A FI71145C FI 71145 C FI71145 C FI 71145C FI 822471 A FI822471 A FI 822471A FI 822471 A FI822471 A FI 822471A FI 71145 C FI71145 C FI 71145C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- pyridin
- group
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/32—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55159016A JPS5782390A (en) | 1980-11-11 | 1980-11-11 | Carbostyril derivative |
| JP15901680 | 1980-11-11 | ||
| JP55179950A JPS57102888A (en) | 1980-12-18 | 1980-12-18 | Carbostyril derivative |
| JP17995080 | 1980-12-18 | ||
| JP8100328 | 1981-11-11 | ||
| PCT/JP1981/000328 WO1982001706A1 (en) | 1980-11-11 | 1981-11-11 | Carbostyril compounds,composition containing same,and process for their preparation |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI822471A0 FI822471A0 (fi) | 1982-07-12 |
| FI822471L FI822471L (fi) | 1982-07-12 |
| FI71145B FI71145B (fi) | 1986-08-14 |
| FI71145C true FI71145C (fi) | 1986-11-24 |
Family
ID=26485945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI822471A FI71145C (fi) | 1980-11-11 | 1982-07-12 | Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4414390A (en, 2012) |
| EP (1) | EP0052016B1 (en, 2012) |
| KR (1) | KR880001657B1 (en, 2012) |
| AT (1) | AT382376B (en, 2012) |
| AU (1) | AU547586B2 (en, 2012) |
| CA (1) | CA1164459A (en, 2012) |
| CH (1) | CH653684A5 (en, 2012) |
| DE (1) | DE3152512T1 (en, 2012) |
| DK (1) | DK157193C (en, 2012) |
| ES (1) | ES507545A0 (en, 2012) |
| FI (1) | FI71145C (en, 2012) |
| IT (1) | IT8149680A0 (en, 2012) |
| MX (1) | MX6802E (en, 2012) |
| NO (1) | NO157819C (en, 2012) |
| PH (1) | PH17158A (en, 2012) |
| PT (1) | PT73959B (en, 2012) |
| SE (1) | SE440653B (en, 2012) |
| SU (1) | SU1215621A3 (en, 2012) |
| WO (1) | WO1982001706A1 (en, 2012) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537889A (en) * | 1982-12-27 | 1985-08-27 | Eli Lilly And Company | Inotropic agents |
| US4636502A (en) * | 1982-12-27 | 1987-01-13 | Eli Lilly And Company | Methods of producing a positive inotropic effect or vasodilation by administration of 2-phenyl imidazo pyrimidines and pyrazines |
| GB8305245D0 (en) * | 1983-02-25 | 1983-03-30 | Fujisawa Pharmaceutical Co | Imidazo-heterocyclic compounds |
| US4533734A (en) * | 1983-11-10 | 1985-08-06 | Eli Lilly And Company | Inotropic agents |
| PT79699B (en) * | 1983-12-22 | 1986-12-10 | Pfizer | Process for preparing quinolone inotropic agents |
| PT80533B (en) * | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
| US4721721A (en) * | 1984-12-18 | 1988-01-26 | Rorer Pharmaceutical Corporation | 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses |
| FR2580646A1 (fr) * | 1985-04-19 | 1986-10-24 | Synthelabo | Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique |
| US4666913A (en) * | 1985-11-22 | 1987-05-19 | William H. Rorer, Inc. | Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8619902D0 (en) * | 1986-08-15 | 1986-09-24 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8709448D0 (en) * | 1987-04-21 | 1987-05-28 | Pfizer Ltd | Heterobicyclic quinoline derivatives |
| CA2191979A1 (en) * | 1994-06-20 | 1995-12-28 | Muneo Takatani | Condensed imidazole compounds, their production and use |
| US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| DE10117184A1 (de) * | 2001-04-05 | 2002-10-17 | Gruenenthal Gmbh | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
| DE10247271A1 (de) * | 2002-10-10 | 2004-08-26 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yle |
| PE20050211A1 (es) * | 2003-04-02 | 2005-04-27 | Novartis Ag | Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas |
| DE102005019181A1 (de) * | 2005-04-25 | 2006-10-26 | Novartis Ag | Peptid-Deformylase (PDF) Inhibitoren 1 |
| EP2334675B1 (en) | 2008-09-16 | 2014-03-26 | Csir | Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
| ES2362894B1 (es) * | 2009-11-16 | 2012-05-21 | Ferrer Internacional S.A. | Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico. |
| CN107810188B (zh) * | 2015-04-08 | 2020-09-22 | 拜耳作物科学股份公司 | 作为害虫防治剂和中间体产物的稠合双环杂环衍生物 |
| CN108137514A (zh) | 2015-07-30 | 2018-06-08 | 百时美施贵宝公司 | 芳基取代的二环杂芳基化合物 |
| EP3484878B1 (en) * | 2016-07-14 | 2020-08-19 | Bristol-Myers Squibb Company | Bicyclic heteroaryl substituted compounds |
| EP3484894B1 (en) | 2016-07-14 | 2020-08-19 | Bristol-Myers Squibb Company | Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1473819A (en) * | 1976-01-28 | 1977-05-18 | Gallardo Antonio Sa | Derivatives of imidazo 1,2-a pyridine |
| EP0007525A1 (de) * | 1978-07-18 | 1980-02-06 | Hoechst Aktiengesellschaft | 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung |
| ES8100016A1 (es) * | 1978-07-18 | 1980-04-01 | Hoechst Ag | Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina. |
| JPS5553284A (en) * | 1978-10-12 | 1980-04-18 | Yoshitomi Pharmaceut Ind Ltd | Pyridazinone derivative |
| GB2031404A (en) * | 1978-10-17 | 1980-04-23 | Yoshitomi Pharmaceutical | Pyridazinone compounds |
-
1981
- 1981-10-29 CA CA000389034A patent/CA1164459A/en not_active Expired
- 1981-11-10 PT PT73959A patent/PT73959B/pt not_active IP Right Cessation
- 1981-11-10 PH PH26478A patent/PH17158A/en unknown
- 1981-11-11 AU AU78085/81A patent/AU547586B2/en not_active Ceased
- 1981-11-11 EP EP81305344A patent/EP0052016B1/en not_active Expired
- 1981-11-11 IT IT8149680A patent/IT8149680A0/it unknown
- 1981-11-11 WO PCT/JP1981/000328 patent/WO1982001706A1/ja active IP Right Grant
- 1981-11-11 US US06/403,582 patent/US4414390A/en not_active Expired - Lifetime
- 1981-11-11 KR KR1019810004359A patent/KR880001657B1/ko not_active Expired
- 1981-11-11 DE DE813152512T patent/DE3152512T1/de active Granted
- 1981-11-11 MX MX819760U patent/MX6802E/es unknown
- 1981-11-11 ES ES507545A patent/ES507545A0/es active Granted
- 1981-11-11 AT AT0908381A patent/AT382376B/de not_active IP Right Cessation
- 1981-11-11 CH CH4324/82A patent/CH653684A5/fr not_active IP Right Cessation
-
1982
- 1982-07-08 SE SE8204237A patent/SE440653B/sv not_active IP Right Cessation
- 1982-07-08 DK DK307482A patent/DK157193C/da not_active IP Right Cessation
- 1982-07-09 NO NO82822391A patent/NO157819C/no unknown
- 1982-07-11 SU SU823466402A patent/SU1215621A3/ru active
- 1982-07-12 FI FI822471A patent/FI71145C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO157819B (no) | 1988-02-15 |
| PT73959B (en) | 1983-04-18 |
| EP0052016B1 (en) | 1984-09-05 |
| IT8149680A0 (it) | 1981-11-11 |
| SE8204237L (sv) | 1982-07-08 |
| DE3152512T1 (de) | 1982-11-18 |
| AU7808581A (en) | 1982-06-07 |
| EP0052016A1 (en) | 1982-05-19 |
| FI822471A0 (fi) | 1982-07-12 |
| MX6802E (es) | 1986-07-29 |
| SE440653B (sv) | 1985-08-12 |
| NO157819C (no) | 1988-05-25 |
| ES8301967A1 (es) | 1983-02-01 |
| FI71145B (fi) | 1986-08-14 |
| PT73959A (en) | 1981-12-01 |
| FI822471L (fi) | 1982-07-12 |
| DE3152512C2 (en, 2012) | 1991-01-03 |
| ES507545A0 (es) | 1983-02-01 |
| SU1215621A3 (ru) | 1986-02-28 |
| KR880001657B1 (ko) | 1988-09-05 |
| CH653684A5 (fr) | 1986-01-15 |
| AU547586B2 (en) | 1985-10-24 |
| CA1164459A (en) | 1984-03-27 |
| WO1982001706A1 (en) | 1982-05-27 |
| PH17158A (en) | 1984-06-13 |
| ATA908381A (de) | 1986-07-15 |
| US4414390A (en) | 1983-11-08 |
| DK307482A (da) | 1982-07-08 |
| NO822391L (no) | 1982-07-09 |
| DK157193B (da) | 1989-11-20 |
| AT382376B (de) | 1987-02-25 |
| DK157193C (da) | 1990-04-09 |
| KR830007644A (ko) | 1983-11-04 |
| SE8204237D0 (sv) | 1982-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI71145B (fi) | Foerfarande foer framstaellning av imidazo/1,2-a/-pyridin-2-yl-karbostyrilderivat vilka aer anvaendbara som hjaertmedicin | |
| EP0467248B1 (en) | Pyrazolopyridine compound and processes for preparation thereof | |
| FI77450C (fi) | Foerfarande foer framstaellning av piperazinylsubstituerade karbostyrilderivat, vilka aer anvaendbara som kardiotoniska medel. | |
| DK164451B (da) | 3-aminoquinolinderivat | |
| CZ342595A3 (en) | Purine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| NZ247720A (en) | Diamino substituted quinolone derivatives; pharmaceutical compositions thereof | |
| NZ517324A (en) | 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors | |
| NO318213B1 (no) | Fremgangsmate til fremstilling av imidazokinolinaminer | |
| EP0120589A1 (en) | Imidazo-heterocyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
| HUT52092A (en) | Process for producing 2(1h)-quinolinone derivatives and pharmaceutical compositions comprising same | |
| FI65260B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-1h-tetrazol-5-yl)-4h-pyrimido(2,1-b)benzotiazolderivat | |
| CA2186086A1 (en) | Substituted xanthines | |
| NO842684L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater | |
| WO2002083683A9 (en) | Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists | |
| EP0874849B1 (en) | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives | |
| HU197749B (en) | Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient | |
| US4463007A (en) | Triazoloquinazolinones, and compositions and methods for treating allergic disorders with them | |
| JP2997828B2 (ja) | キノリン及びナフチリジン誘導体 | |
| NL192040C (nl) | Carbostyrilverbindingen en preparaat dat een dergelijke verbinding bevat. | |
| EP0107455A1 (en) | Triazoloquinoxalines as antidepressants and antifatigue agents | |
| US5334595A (en) | Pyrazoloquinolones as anticancer agents | |
| FI77035C (fi) | Foerfarande foer framstaellning av farmakologiskt verkande 5-oxo-5h-pyrido/2,1-b/1h-triazolo/4,5-g/- och /4,5-f/-kinazoliner. | |
| WO2003004494A1 (en) | Pyridazinone compound as adenosine antagonists | |
| US20240092780A1 (en) | Adducts and dimer compounds synthesized using gk method | |
| CS248711B2 (en) | Production method of the/l1,2,4/triazol/4,3-a/chinoxaline-4-amin derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: OTSUKA PHARMACEUTICAL CO. LTD. |